Periodic Reporting for period 1 - RESPILIQ (RESPILIQ - enteral CO2 absorption for the therapy of hypercapnic lung failure)

Chronic Obstructive Pulmonary Disease (COPD) is one of the leading causes of death worldwide, affecting millions of people with a high socioeconomic burden. The major challenge in the treatment of COPD patients is hypercapnia (too much CO2 in the blood). Standard treatment...